Summary Expermental in vitro and animal data support an important role for matrix metalloproteinases (MMPs) in cancer invasion and metastasis via proteolytic degradation of the extracellular matrix (ECM). Our previous data have shown that MMP-9 mRNA is localized to the interface between liver metastasis and normal liver tissue, indicating that MMP-9 may play an important role in liver metastasis formation. In the present study, we analysed the cellular enzymatic expression of MMP-9 in 18 human colorectal cancer (CRC) liver metastasis specimens by enzyme-linked immunosorbent assay (ELISA) and zymography. ELISA anatysis reveals that the latent form of MMP-9 is present in both liver metastasis and paired adjacent normal liver tissue. The mean level of the latent form of MMP-9 is 580±270 ng per mg total tissue protein (mean ± s.e.) in liver metastasis vs 220 ± 90 in normal liver tissue. However, this difference is not significantly different (P = 0.26). Using gelatin zymography, the 92-kDa band representative of the latent form is present in both liver metastasis and normal liver tissue. However, the 82 kDa band, representive of the active form of MMP-9, was seen only in liver metastasis. This was confirmed by Westem blot analysis. Our observation of the unique presence of the active form of MMP-9 within liver metastasis suggests that proMMP-9 activation may be a pivotal event during CRC liver metastasis formation. . emphasizing the clinical importance of elevated MMP-9 expression in primarx CRC.
elexvated MMP-9 actixvitx in experimental colon tumours transplanted into mice has been shown to correlate with metastasizinc (Nakajima et al. 1990 ). Furthermore. oxerexpression of has been obser ed in x-arious human cancers. includinc CRC (1Pxke et al. 1993 : Liabakk et al. 1996 : Nielsen et al. 1996 : Zeng and Guillem. 1996 . breast (Davies et al. 1993a) . bladder (Davies et al. 1993b ). prostate (Hamdy et al. 1994) . lunc (Brown et al. 1993a . squamous cell carcinoma ([N-ke et al. 1992 ) and brain tumours (Rao et al. 1993 Our recently published data hax-e shown that tumour tissue MMP-9 RNA lex-el can predict colorectal cancer relapse and survixal . emphasizing the clinical importance of elevated MMP-9 expression in primarx CRC.
We hax-e previously demonstrated that MMP-9 mRRNA is localized in the interface between lixer metastasis and normal lixer tissue. indicating that MMP-9 may play an important role in lix er metastasis formation. To inxestigate further the significance of elexated (SDS) ] and centrifuged at 5000 g for 20 min at 4"C as prex iously described (Zeng and Guillem. 1996) (1998) 
Zymographic detection of active and latent MMP-9 forms
Gelatin zymography detected both the pro and actix-e forms of NIMP-9 xPith molecular xxweights of 92 and 82 kDa respectix-ely.
The identitx of these activities xvas confirmed wx-ith molecular W-eight standards and the 92-kDa gelatinase positix-e control (medium conditioned bv RA3-1S7 cells). The 92-kDa latent form of MMNIP-9 (proMNMIP-9() w as detected in both liver metastasis and paired normal liver samples. As show-n in Figure 2 . the activated form of MNIP-9 w-as seen onlx in liver metastasis. whereas no active MNIP-9 activitV could be detected by zymography in normal lixer. Fourteen of 18 (77.8 c( liver metastasis samples (cases 1. 2. 4. 5. 6. 8. 9. 10-16) expressed actixated forms of MIMP-9 (82 kDa). MNIP-9 gelatinase activity in liver metastasis and normal liver x-as confirmed by complete inhibition of activitV w-hen duplicate gels wxere incubated in the presence of 10 mm EDTA (data not show-n). To test the possibilitx-of spontaneous actixvation of gelatinases during sample storage. xwe selected txwo paired lixer metastases and corresponding normal lixer samples (cases 17 and 18). both lackin2 the actix-e MMP-9 form. and performed gelatin zymography 1 wxeek. half a month and 1 month after storage at -80^C. Despite prolonged storage. no actixe form w-as detected in both lixver metastasis and lixver (data not shoxn).
Western blot confirmation of active MMP-9
To confirm that the 82 kDa band seen in the gelatin zymography represented activated MIMP-9. MNIP-9 protein expression wxas detected bv Western blot analvsis using MNIMP-9 antibodv Ab 110. wxhich recognizes both the latent and actixated formn of MNIP-9. Figure 4 showxs a representatixe Western blot of MNIP-9 from lix er metastasis and corresponding normal lixver samples (cases 9-121.
In agreement wxith zx mograpy. the 92-kDa band of proMMNIP-9 wx as observed in both lixer metastases and normal lixer tissue. The MNIP-9 form. wxhich is detected in tumours. appears to correspond specifically to the actixvated form of MMNIP-9 (82 kDa). There is verv little. if anx. actix ated forn of NIMP-9 in normal lix-er tissue.
DISCUSSION
Our prexious x ork and that of others hax-e demonstrated that lexels of actixated MNIP-2 and NIMP-9 correlate xith progression of . lung cancer (Brown et al. 1993b ), breast cancer (Davies et al, 1993a) . gastric cancer (Rajabi et al. 1990 ). prostate cancer (Stearns and Wang. 1993) and melanoma (MacDougall et al. 1995) . The present study provides clear evidence that the activated form of MMP-9 is detected only in liver metastasis. not in adjacent normal liver tissue. suggesting that MMP-9 activation is a pivotal event during CRC liver metastasis
formation. The precise mechanism by which MMP-9 is synthesized and secreted remains unknown. However, it has become apparent that the intracellular signalling events controlling MMP-9 production are likely to involve tumour-stroma cellular interactions. As MMP-9 is secreted in a latent form, activation must occur in order to ensure extracellular matrix substrate degradation. This is accomplished by cleavage at the Glu-40-Met-41 amide bond located in the middle of the propeptide to generate an 86-kDa intermediate. Cleavage of this bond triggers a change in proMMP-9 that renders the Arg-87-Phe-88 amide bond susceptible to the second cleavage, resulting in conversion to an 82-kDa species (Ogata et al. 1992 : Fridman et al, 1995 . ProMMP-9 can be activated autocatalytically by organomercurial compounds or trypsin in vitro (Wilhelm et al, 1989; Lyons et al, 1991 ). In the current study. the possibility of spontaneous activation of gelatinases in liver metastasis during sample processing appears to be unlikely, as the liver metastasis and control normal liver samples were processed in an identical manner and run on the same gel. In addition, tissue samples initially negative for the active 82-kDa band remained negative despite storage and repeat analysis at different time points.
Several studies have demonstrated that MMPs have the ability to activate one another (Ogata et al, 1992; O'Connell et al, 1994; Cao et al. 1995 : Fridman et al, 1995 . Stromelysin (MMP-3) has been shown to activate proMMP-9, and ProMMP-3 can be activated by plasmin and cathepsin B. MT-MMPs, which are found on the cell membrane of tumour cells, have been shown to activate MMP-2 (Sato et al. 1994) . The complex of proMMP-2 and TTIMP-2 binds to activated MT-MMP and this binding ultimately results in activation of MMP-2 (Himelstein et al, 1994; Cao et al. 1995 (Zeng and Guillem, 1995) . However. ELISA and zymographic analysis detect pro-MMP-9 enzyme in both liver metastasis and normal liver tissue. It is difficult to explain this inconsistency. except that there may be factors that control both MMP-9 RNA up-regulation and proenzyme activation. In addition. MMP-9 activation in liver metastasis was not uniform (78% rather than 100%). supporting the notion that MMP-9 activation may not be the only mechanism involved in liver metastasis formation. Our in situ and immunohistochemistry data indicate MMP-9 production by macrophages in liver metastasis (Zeng and Guillem. 1995) . Because not all macrophages contain detectable amounts of MMP-9. this may be due to differences among various macrophage subpopulations (Heuff et al, 1993) . It is reported that tumour-associated macrophages (TAMs) may be involved in the development of liver metastasis (Martin et al. 1989 : Heuff et al. 1993 . Heuff et al (1993) observed tumourinfiltrating macrophages. a peculiar type of TAM. in a rat liver metastasis model. As many tumours produce factors such as macrophage colony-stimulating factor (M-CSF) (Walter et al. 1991) and as TAM may bear receptors for M-CSF (Bottazi et al. 1990 ), tumour cells may stimulate the migration and growth of tumour-associated macrophages to the tumour edge, leading to increased local MMP-9 production facilitating tumour invasion. This notion is supported by the identification of agents such as lipopolysaccharide (LPS), which can stimulate macrophages to produce several MMPs including MMP-9 (Welgus et al. 1990; Xie et al. 1994) . as well as our work, which demonstrates that metastastic CRC cells can stimulate THP-1 monocytes to produce MMP-9 (Swallow et al. 1996) . Further support for an important role of macrophage-derived MMPs in invasion comes from studies using macrophage metalloproteinase (MMP-12 or MME)-deficient mice (MME-/-). Macrophages of MME-/-mice have a markedly diminished capacity to degrade ECM components. MME-/-macrophages are essentially unable to penetrate reconstituted basement membrane in vitro or in vivo (Shipley et al, 1996) .
In conclusion, our results demonstrate the presence of proMMP-9 in both liver metastasis and normal liver tissue. However, the active form of MMP-9 is detected only in liver metastasis. These results support the notion that proMMP-9 activation is a pivotal event during liver metastasis formation. An enhanced understanding of the molecular mechanisms responsible for the activation of pro-MMP-9 may lead to the development of novel methods for the prevention and treatment of liver metastasis.
